Publicatie

Publicatie datum
Protocol for a phase II, monocenter, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2, 3 and 4 (SPACE trial).
Stam, M., Wadman, R.I., Wijngaarde, C.A., Bartels, B., Asselman, F.L., Otto, L.A.M., Goedee, H.S., Habets, L.E., Groot, J.F. de, Schoenmakers, M.A., Cuppen, I., Berg, L.H. van den, Pol, W.L. van der. Protocol for a phase II, monocenter, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2, 3 and 4 (SPACE trial). BMJ Open: 2018, 8(7), e019932
Lees online
Vragen, bel of mail:
J.F. (Janke) de Groot
Programmaleider Kwaliteit en Organisatie van care en cure